Details of the Drug Reposition

General Information of This Drug (ID: DMX04CA)

• Drug Name: VB-111 (DMX04CA)

Information on Drug Reposition of This Drug

2 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Malignant glioma	DISFXKOV	2A00.0	Phase 3	[1]
Ovarian cancer	DISZJHAP	2C73	Phase 3	[2]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)